WE DISCOVER AND DEVELOP NOVEL,
DIFFERENTIATED THERAPIES IN CANCER AND BEYOND
ADDRESS UNMET MEDICAL NEEDS FOR PATIENTS IN CHINA AND GLOBALLY
Founded in 2016, we have established a robust in-house R&D engine underpinned by an oustanding discovery team and multi-dimensional discovery platform. We have strategically designed and developed a rich pipeline of 14 small molecule programs focused on oncology.